Companies from across the supplement supply chain advocate for a transparent industry and empower consumers to take control of their health. We tell the supplement industry’s story through content, research and education-based events.

Supplement industry news and updates – August 2022

Inside the Bottle brings you the latest supplement industry news in this monthly roundup.

August 23, 2022

2 Min Read
ITB21_Newsletter_1540x800_0.jpg

Industry responds to JAMA’s “Supplements are a waste of money” report—article

The U.S. Preventive Services Task Force (USPSTF) issued new guidance in the Journal of the American Medical Association saying it found “insufficient evidence” taking multivitamins, paired supplements or single supplements can help prevent cardiovascular disease and cancer in otherwise healthy adults. Read industry leaders’ responses here and here

The recession’s already here, say supplement execs—article

Learn why industry veterans believe we’re already in a downturn, and how manufacturers can handle consumers’ reduced discretionary income, supply chain challenges and other macroeconomic forces—and why the industry has been traditionally resilient during economic downturns. Read more here.

Top 3 takeaways from NBJ/s Global Supplement Business Report—article

Find out from NBJ’s lead analyst how COVID variants, China’s not-so-sharp sales spike and the vitamins and minerals category shaped worldwide sales growth and how it compares to pre-pandemic growth rates here. Find more in-depth business analysis like this in Nutrition Business Journal. Read more here.

Beyond probiotics and gut health, microbiome sales soar with increasing consumer awareness – analysis

Probiotic sales soar with increasing consumer awareness. More people than ever are making the connection between gut health and overall wellness. In cooperation with ITB partners Wakunaga and SPINS, the latest Inside the Bottle Trend Spotlight sheds light on consumer supplement buying patterns in this high growth category. Learn about how analysts predict the market could change after a year that experienced 18% growth in probiotics. Read all about it here.

Showdown in Congress over FDA user fee bill—article

The new legislation, which contains no “dietary supplement” provisions, may have massive implications for manufacturers and distributors of dietary supplements. Get the details on Sen. Richard Burr (R-N-C)’s bill and reactions from other lawmakers and the Natural Products Association, the American Herbal Products Association and the Council for Responsible Nutrition here. Read more here.

Top 10 challenges for ingredients and supplement companies—slideshow

Which are keeping you up at night? From Amazon to the FDA, there’s no shortage of issues complicating the industry. See how they reach across borders and baskets and find out which may hold silver linings of possibility for the future? View here.

 

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like